by Targeted drug delivery involves the administration of pharmaceutical compounds, nanocarriers, polymeric conjugates or other drug delivery systems directly to the site of action in the body to achieve the desired therapeutic effect. This reduces overall toxicity and improves therapeutic efficacy by increasing drug accumulation in diseased tissues while minimizing its exposure to healthy tissues. The global targeted drug delivery market offers promising solutions for the treatment of cancer, ocular diseases, infectious disorders and other conditions.
The global Targeted Drug Delivery Market is estimated to be valued at US$ 761.95 Mn in 2023 and is expected to exhibit a CAGR of 9.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The growth of the targeted drug delivery market is majorly driven by the increased demand for personalized therapeutics. Targeted drug delivery aids in developing personalized treatment options for patients depending on factors like genetic makeup, disease pathology and severity. This allows for tailoring drug formulations based on an individual’s unique medical needs. As research advances in fields like nanotechnology and material engineering, newer targeted delivery systems are being designed with improved specificity and controlled drug release profiles. This significantly improves treatment outcomes for chronic and complex diseases.
SWOT Analysis
Strength: Targeted drug delivery allows for precise concentration of drugs at disease sites, reducing side effects. It improves bioavailability and pharmacokinetics of drugs.
Weakness: High development costs and complexity of manufacturing targeted delivery systems pose challenges. Limited knowledge about disease biology hampers development of efficient targeting ligands.
Opportunity: Rising incidence of cancers and other chronic diseases drive demand for targeted therapies. Nanotechnology advances enable development of novel targeted delivery systems.
Threats: Stringent regulatory approval process increases costs and timelines. Emergence of alternative drug delivery technologies.
Key Takeaways
The Global Targeted Drug Delivery Market Size is expected to witness high growth. The global Targeted Drug Delivery Market is estimated to be valued at US$ 761.95 Mn in 2023 and is expected to exhibit a CAGR of 9.5% over the forecast period 2023 to 2030.
Regional analysis:
North America dominates the targeted drug delivery market currently due to high adoption of advanced therapies and presence of major players. Asia Pacific is expected to grow at the fastest pace due to rising healthcare investments, westernization of lifestyles, and improving access to innovative therapies.
Key players analysis:
Key players operating in the targeted drug delivery market are AbbVie Inc., Ablynx NV by Sanofi SA, Arrowhead Pharmaceuticals, Inc., Baxter International Inc., AstraZeneca PLC, Boston Scientific Corporation, Becton, Depomed, Inc., Fraunhofer Gesellschaft Munchen, Janssen Global Services, LLC., Luye Pharma Group, Pfizer Inc., Quark Pharmaceuticals Inc., Rexahn Pharmaceuticals Inc., Savara Inc., Roche Holding AG, Suda Limited, Vectura Group PLC, Taiwan Liposome Company, Ltd., and 3M Company.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.
